Bibliografía del artículo
1. Gisbert JP. Is gastric lymphoma an infectious disease? Med Clin (Barc) 110:56-61, 1998.
2. Dogusoy G, Karayel FA, Gocener S, Goksel S. Histopathologic features and expression of Bcl-2 and p53 proteins in primary gastric lymphomas. Pathol Oncol Res 5:36-40, 1999.
3. Jonkers D, Gisbertz I, De Bruine A, et al. Helicobacter pylori and non-Helicobacter pylori bacterial flora in gastric mucosal and tumour specimens of patients with primary gastric lymphoma. Eur J Clin Invest 27:885-92, 1997.
4. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575-7, 1993.
5. Nakamura S, Matsumoto T, Suekane H, et al. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. Cancer 104:532-40, 2005.
6. Montalban C, Manzanal A, Boixeda D, et al. Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Follow-up of the histological and molecular response. Med Clin (Barc) 110:41-4, 1998.
7. Lee SK, Lee YC, Chung JB, et al. Low grade gastric mucosa associated lymphoid tissue lymphoma: treatment strategies based on 10 year follow-up. World J Gastroenterol 10:223-6, 2004.
8. Yeh HZ, Chen GH, Chang WD, et al. Long-term follow up of gastric low-grade mucosa-associated lymphoid tissue lymphoma by endosonography emphasizing the application of a miniature ultrasound probe. J Gastroenterol Hepatol 18:162-7, 2003.
9. Lehours P, Ruskone-Fourmestraux A, Lavergne A, Cantet F, Megraud F. Which test to use to detect Helicobacter pylori infection in patients with low-grade gastric mucosa-associated lymphoid tissue lymphoma? Am J Gastroenterol 98:291-5, 2003.
10. Ruskone-Fourmestraux A, Lavergne A, Aegerter PH, et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 48:297-303, 2001.
11. Delchier JC, Lamarque D, Levy M, et al. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type. Am J Gastroenterol 96:2324-8, 2001.
12. Hiyama T, Haruma K, Kitadai Y, et al. Clinicopathological features of gastric mucosa-associated lymphoid tissue lymphoma: a comparison with diffuse large B-cell lymphoma without a mucosa-associated lymphoid tissue lymphoma component. J Gastroenterol Hepatol 16:734-9, 2001.
13. Cuttner J, Werther JL, McGlynn P, et al. Seroprevalence of Helicobacter pylori infection in patients with lymphoma. Leuk Lymphoma 40:591-7, 2001.
14. Ben Rejeb A, Kchir N, Bouali MR, et al. Gastric MALT lymphoma. A clinico-pathological study of 65 cases. Relationship to Helicobacter pylori. Tunis Med 78:484-93, 2000.
15. Arista-Nasr J, Herrera-Goepfert R, Lazos-Ochoa M, Pichardo R. Histologic changes of the gastric mucosa associated with primary gastric lymphoma in endoscopic biopsy specimens. Arch Pathol Lab Med 124:1628-31, 2000.
16. Fischbach W, Jung T, Goebeler-Kolve M, Eck M. Comparative analysis of the Helicobacter pylori status in patients with gastric MALT-type lymphoma and their respective spouses. Z Gastroenterol 38:627-30, 2000.
17. Konturek PC, Konturek SJ, Starzyska T, et al. Helicobacter pylori-gastrin link in MALT lymphoma. Aliment Pharmacol Ther 14:1311-8, 2000.
18. Ohashi S, Segawa K, Okamura S, et al. A clinicopathologic study of gastric mucosa-associated lymphoid tissue lymphoma. Cancer 88:2210-9, 2000.
19. Steinbach G, Ford R, Glober G, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 131:88-95, 1999.
20. Eck M, Greiner A, Schmausser B, et al. Evaluation of Helicobacter pylori in gastric MALT-type lymphoma: differences between histologic and serologic diagnosis. Mod Pathol 12:1148-51, 1999.
21. Yi Z, Ouyang Q, Li G. Investigation of relationship between primary gastric malignant lymphoma and Helicobacter pylori infection. Zhonghua Nei Ke Za Zhi 36:442-5, 1997.
22. Bouzourene H, Haefliger T, Delacretaz F, Saraga E. The role of Helicobacter pylori in primary gastric MALT lymphoma. Histopathology 34:118-23, 1999.
23. Chang DK, Chin YJ, Kim JS, et al. Lymph node involvement rate in low-grade gastric mucosa-associated lymphoid tissue lymphoma--too high to be neglected. Hepatogastroenterology 46:2694-700, 1999.
24. Vallina E, Fresno F, Alonso JL, Madrigal B, Arribas JM. Incidence of primary gastric lymphoma and H. pylori infection in the central zone of Asturias. An Med Interna 16:175-7, 1999.
25. Oberhuber G, Kranz A, Dejaco C, et al. Blood groups Lewis(b) and ABH expression in gastric mucosa: lack of inter-relation with Helicobacter pylori colonisation and occurrence of gastric MALT lymphoma. Gut 41:37-42, 1997.
26. Pavlick AC, Gerdes H, Portlock CS. Endoscopic ultrasound in the evaluation of gastric small lymphocytic mucosa-associated lymphoid tumors. J Clin Oncol 15:1761-6, 1997.
27. Eck M, Schmausser B, Haas R, Greiner A, Czub S, Muller-Hermelink HK. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 112:1482-6, 1997.
28. Xu WS, Ho FC, Ho J, Chan AC, Srivastava G. Pathogenesis of gastric lymphoma: the enigma in Hong Kong. Ann Oncol 8(Supl 2):41-4, 1997.
29. Gisbertz IA, Jonkers DM, Arends JW, et al. Specific detection of Helicobacter pylori and non-Helicobacter pylori flora in small- and large-cell primary gastric B-cell non-Hodgkin's lymphoma. Ann Oncol 8(Supl 2):33-6, 1997.
30. Nakamura S, Yao T, Aoyagi K, Iida M, Fujishima M, Tsuneyoshi M. Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients. Cancer 79:3-11, 1997.
31. Chiang IP, Wang HH, Cheng AL, Lin JT, Su IJ. Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue: clinicopathologic analysis of 19 cases. J Formos Med Assoc 95:857-65, 1996.
32. Herrera-Goepfert R, Garcia-Marcano R, Zeichner-Gancz I. Helicobacter pylori and lymphoid follicles in primary gastric MALT-lymphoma in Mexico. Rev Invest Clin 48:261-5, 1996.
33. Cammarota G, Tursi A, Montalto T, et al. Clinical assessment of the relationship of Helicobacter pylori to gastroduodenal pathologies. A prospective analysis of 253 consecutive patients. Panminerva Med 37:178-81, 1995.
34. Miettinen A, Karttunen TJ, Alavaikko M. Lymphocytic gastritis and Helicobacter pylori infection in gastric lymphoma. Gut 37:471-6, 1995.
35. Karat D, O'Hanlon DM, Hayes N, Scott D, Raimes SA, Griffin SM. Prospective study of Helicobacter pylori infection in primary gastric lymphoma. Br J Surg 82:1369-70, 1995.
36. Calvert R, Randerson J, Evans P, et al. Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet 345:26-7, 1995.
37. Muller-Hermelink HK, Ott G, Ott M, Greiner A. Pathology and pathogenesis of extranodal lymphomas in the gastrointestinal tract. Schweiz Rundsch Med Prax 84:1416-22, 1995.
38. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330:1267-71, 1994.
39. Eidt S, Stolte M, Fischer R. Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas. J Clin Pathol 47:436-9, 1994.
40. Fagioli F, Rigolin GM, Cuneo A, et al. Primary gastric lymphoma: distribution and clinical relevance of different epidemiological factors. Haematologica 79:213-7, 1994.
41. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175-6, 1991.
42. Ruskone-Fourmestraux A, Rambaud JC. Gastrointestinal lymphoma: prevention and treatment of early lesions. Best Pract Res Clin Gastroenterol 15:337-54, 2001.
43. Fischbach W, Goebeler-Kolve ME, Dragosics B, Greiner A, Stolte M. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 53:34-7, 2004.
44. Levy M, Copie-Bergman C, Traulle C, et al. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. Am J Gastroenterol 97:292-7, 2002.
45. Gisbert JP, Aguado B, Luna M, et al. Gastric MALT lymphoma: clinical characteristics and prevalence of H. pylori infection in a series of 37 cases. Rev Esp Enferm Dig 98:655-65, 2006.
46. Montalban C, Santon A, Boixeda D, et al. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Haematologica 86:609-17, 2001.
47. Diz-Lois Palomares MT, Souto Ruzo J, Yanez Lopez JA, Alvarez Garcia A, Arnal Monreal F, Vazquez-Iglesias JL. Early-stage gastric MALT lymphomas: eradication of H. pylori and outcome. Rev Esp Enferm Dig 94:669-78, 2002.
48. Mones J, Gisbert JP, Borda F, Dominguez-Munoz E. Indications, diagnostic tests and Helicobacter pylori eradication therapy. Recommendations by the 2nd Spanish Consensus Conference. Rev Esp Enferm Dig 97:348-74, 2005.